Intellia Therapeutics, Inc. (NTLA): 4 filed Nov 3, 2026

Form type

4

Filing date

Nov 3, 2026

Accession number

0001193125-26-445417

Filer

Intellia Therapeutics, Inc. (CIK 1652130)